Purchase Order HHSD2002013M57226P

This is a 2020 contract awarded by the Centers for Disease Control and Prevention (CDC), part of the Department of Health and Human Services, to Genesis Laboratories, Inc., a for-profit subchapter S corporation. The $149,147 firm fixed-price contract is for products and services related to vector-borne disease research and prevention, specifically controlling tick populations and reducing Lyme disease incidence. Under this definitive contract, Genesis Laboratories will provide fipronil-laced...

The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $1.7 million firm fixed price delivery order against its NIAID Preclinical Models of Infectious Diseases 2017-2024 master IDIQ contract to Sigmovir Biosystems, Inc. for development of a cotton rat model for the evaluation of vaccines and therapeutics for respiratory syncytial virus and related viruses. Work will be performed by Sigmovir Biosystems in Potomac, Maryland through March 2023. The NIAID...

This is a $9,541,642.00 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Health Research, Inc. (HRI), a non-profit organization in Menands, New York. The contract is for the discovery and characterization of human B cell epitopes on bacterial surface antigens involved in immunity to Borrelia burgdorferi infection, the causative agent of...

This is a $10,279,321.93 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Health Research, Inc. (HRI), a non-profit organization. The contract is for "LYME DISEASE: B CELL EPITOPE DISCOVERY AND MECHANISMS OF ANTIBODY PROTECTION" and has a completion date of September 15, 2025. The contract is a cost-no-fee arrangement and was not set aside for any specific business...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price definitive contract to Inc. T.erry L. Schulze, Phd, a for-profit S-corporation, for tick management services. The contract, valued at $97,035.00, will run from September 26, 2023 to March 31, 2025, and will involve tick habitat management, tick-borne disease management feasibility studies, and evaluations of acaricide application methods for the CDC's Pittsburgh office. This award is...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $91,194.89 firm-fixed-price purchase order contract to the Old Dominion University Research Foundation (ODURF) to use an updated version of the LYMESIM computer simulation model for Lyme disease prevention strategies. This work was not set aside for any special program. ODURF is a non-profit organization that manages a diverse portfolio of federal contracts and grants across scientific and technical domains, frequently...

This is a firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Inc. T.erry L. Schulze, Phd, a for-profit S-corporation. The contract, valued at $100,000.00, is for tick management, tick habitat management, tick-borne disease management feasibility studies, and evaluations of acaricide (pesticide for killing ticks) application methods. The contract has an ultimate completion date of August 20, 2018 and was awarded on August 21, 2017. The award was not...

This is a $620,310.00 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Genesis Laboratories, Inc., a for-profit subchapter S corporation, to conduct a field trial of fipronil-laced oral bait. The contract, which has an ultimate completion date of August 24, 2026, is intended to support the CDC's vector-borne disease program by controlling tick populations and reducing Lyme disease incidence. Genesis Laboratories has previously conducted...

Research Triangle Institute (RTI) International has been awarded a firm-fixed-price contract valued at $1,282,546 by the Centers for Disease Control and Prevention (CDC) to develop a web-based systems science simulation model to evaluate the health and economic impact of policies and programs addressing social determinants of health. The original solicitation sought proposals for a simulation capable of assessing intervention effectiveness and cost-effectiveness over five years, estimating...

This is a cost-plus-fixed-fee contract awarded to Westat, Inc. by the Centers for Disease Control and Prevention (CDC) to provide services for "STRENGTHENING LYME DISEASE SURVEILLANCE". The contract has a total ceiling value of $2,950,954.00 and a performance period ending on September 29, 2026. Westat, a professional services firm based in Rockville, Maryland, has extensive experience supporting federal agencies in areas such as public health, education, and social policy. This...